The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABEONA THERAPEUTICS INC | COM | 00289Y107 | 4,122 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 5,370 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ACORDA PHARMACEUTICALS | COM | 00484M106 | 3,522 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | ||
AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 3,688 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONSORED ADR | 023111206 | 13,390 | 645,000 | SH | SOLE | 645,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 2,243 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 11,182 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 10,926 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
AVENUE THERAPEUTICS INC | COM NEW | 05360L205 | 3,800 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 23,166 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADR | 09071M106 | 108 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 10,407 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 3,924 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 9,308 | 1,825,000 | SH | SOLE | 1,825,000 | 0 | 0 | ||
CERECOR INC | COM | 15671L109 | 13,432 | 2,300,000 | SH | SOLE | 2,300,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 2,016 | 960,000 | SH | SOLE | 960,000 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 2,650 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
CLEMENTIA PHARMACEUTICALS INC | COM | 185575107 | 10,443 | 400,130 | SH | SOLE | 400,130 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 30,282 | 1,475,000 | SH | SOLE | 1,475,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 1,661 | 73,000 | SH | SOLE | 73,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 7,304 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
CYTOKINETICS | COM NEW | 23282W905 | 6,877 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 7,891 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 5,420 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
EIDOS THERAPEUTICS INC | COM | 28249H104 | 4,690 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 16,912 | 1,365,000 | SH | SOLE | 1,365,000 | 0 | 0 | ||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 1,202 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 6,118 | 764,773 | SH | SOLE | 764,773 | 0 | 0 | ||
FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 3,056 | 630,000 | SH | SOLE | 630,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 10,870 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 675 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
FORTRESS BIOTECH INC | COM | 034960Q19 | 3,560 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
HARROW HEALTH | COM | 45323A201 | 8,964 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | ||
HORIZON PHARMA PLC | SHS | G4617B105 | 4,890 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 10,305 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 418 | 25,200 | SH | SOLE | 25,200 | 0 | 0 | ||
LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 386 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
LIQUIDIA TECHNOLOGIES INC | COM | 53635D202 | 2,561 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 8,400 | 510,000 | SH | SOLE | 510,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 7,697 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 7,543 | 1,900,000 | SH | SOLE | 1,900,000 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 7,186 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 8,047 | 213,800 | SH | SOLE | 213,800 | 0 | 0 | ||
RETROPHIN INC | COM | 761299106 | 4,639 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
SHOCKWAVE MED INC | COM | 82489T104 | 3,083 | 92,100 | SH | SOLE | 92,100 | 0 | 0 | ||
STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 5,739 | 1,152,500 | SH | SOLE | 1,152,500 | 0 | 0 | ||
SYNTHORX INC | COM | 87167A103 | 815 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 10,983 | 1,366,062 | SH | SOLE | 1,366,062 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 6,372 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 12,228 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 4,821 | 485,000 | SH | SOLE | 485,000 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 4,952 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 890 | 55,000 | SH | SOLE | 55,000 | 0 | 0 |